Roberto Hegg
Impact in
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 53
- HER2/EGFR in Cancer Research 30
- Cancer Treatment and Pharmacology 19
- Cancer Immunotherapy and Biomarkers 4
-
- Advanced Breast Cancer Therapies 30
- Co-authors
- Seock‐Ah Im (7 shared papers)Hiroji Iwata (10 shared papers)Carlos H. Barrios (7 shared papers)Javier Cortés (21 shared papers)Luciana Molinero (5 shared papers)Jane Yuet Ching Hui (3 shared papers)Peter Schmid (4 shared papers)Hope S. Rugo (3 shared papers)
- Journals
- Journal of Clinical Oncology (18 papers)Annals of Oncology (17 papers)Cancer Research (8 papers)Breast Cancer Research and Treatment (5 papers)European Journal of Cancer (4 papers)
- Partner nations
- BrazilUnited StatesSpain
In The Last Decade
Roberto Hegg
81 papers receiving 8.5k citations
Roberto Hegg's Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 5.6k
- Cancer Research 1.8k
- Pulmonary and Respiratory Medicine 1.8k
- Immunology 1.2k
- Radiology, Nuclear Medicine and Imaging 1.1k
Countries citing papers authored by Roberto Hegg
This map shows the geographic impact of Roberto Hegg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Hegg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Hegg more than expected).
Fields of papers citing papers by Roberto Hegg
This network shows the impact of papers produced by Roberto Hegg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Hegg. The network helps show where Roberto Hegg may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Hegg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer Hit paper breakdown → | 2018 | 3127 |
| 2 | Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer Hit paper breakdown → | 2011 | 1865 |
| 3 | Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA) Hit paper breakdown → | 2013 | 821 |
| 4 | Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial Hit paper breakdown → | 2020 | 747 |
| 5 | 2012 | 269 | |
| 6 | 2019 | 166 | |
| 7 | 2018 | 149 | |
| 8 | 2016 | 140 | |
| 9 | 2014 | 113 | |
| 10 | 2020 | 82 | |
| 11 | 2021 | 77 | |
| 12 | 2012 | 68 | |
| 13 | 2014 | 67 | |
| 14 | 2017 | 66 | |
| 15 | 2002 | 64 | |
| 16 | 2008 | 59 | |
| 17 | 2016 | 59 | |
| 18 | 2019 | 59 | |
| 19 | 2012 | 56 | |
| 20 | 2016 | 55 |
About Roberto Hegg
Roberto Hegg is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Public Health, Environmental and Occupational Health, having authored 89 papers that have together received 8.6k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (30 papers), HER2/EGFR in Cancer Research (30 papers), Cancer Treatment and Pharmacology (19 papers), Breast Cancer Treatment Studies (16 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Cancer, Lipids, and Metabolism (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Oncology (5.6k citations), Cancer Research (1.8k citations), Pulmonary and Respiratory Medicine (1.8k citations), Immunology (1.2k citations) and Radiology, Nuclear Medicine and Imaging (1.1k citations). Roberto Hegg has collaborated with scholars based in Brazil, United States and Spain. Frequent co-authors include Seock‐Ah Im, Hiroji Iwata, Carlos H. Barrios, Javier Cortés, Luciana Molinero, Jane Yuet Ching Hui, Peter Schmid, Hope S. Rugo, Andreas Schneeweiss and Sylvia Adams. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Breast Cancer Research and Treatment and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.